TITLE

New ideas on the pathophysiology and treatment of lung disease

AUTHOR(S)
Rogers, D. F.; Laurent, G. J.
PUB. DATE
March 1998
SOURCE
Thorax;Mar1998, Vol. 53 Issue 3, p200
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
No abstract available.
ACCESSION #
66296795

 

Related Articles

  • State of progress in treating cystic fibrosis respiratory disease. Flume, Patrick A.; Van Devanter, Donald R. // BMC Medicine;2012, Vol. 10 Issue 1, p88 

    Since the discovery of the gene associated with cystic fibrosis (CF), there has been tremendous progress in the care of patients with this disease. New therapies have entered the market and are part of the standard treatment of patients with CF, and have been associated with marked improvement...

  • Theravance, Glaxo Stocks Rise On Lung Drug Approval. AMY REEVES // Investors Business Daily;5/10/2013, p00 

    Breo Ellipta, a new treatment for chronic lung disease developed by

  • Diagnosis and Treatment of Pulmonary Hypertension.  // American Family Physician;5/1/2001, Vol. 63 Issue 9, p1789 

    Focuses on the diagnosis and treatment of pulmonary hypertension. Epidemiology; Pathophysiology; Clinical presentation; Diagnostic evaluation; Effectiveness of calcium channel blockers and anticoagulation agents in the treatment of the disease; Options for lung transplantation.

  • Pulmonary manifestations of sickle cell disease. Siddiqui A K; Ahmed S // Postgraduate Medical Journal;Jul2003, Vol. 79 Issue 933, p384 

    Pulmonary complications account for significant morbidity and mortality in patients with sickle cell disease. Clinical lung involvement manifests in two major forms: the acute chest syndrome and sickle cell chronic lung disease. Acute chest syndrome is characterised by fever, chest pain, and...

  • Update in Nonneoplastic Lung Diseases. Gordon, Ilyssa O.; Cipriani, Nicole; Arif, Qudsia; Mackinnon, A. Craig; Husain, Aliya N. // Archives of Pathology & Laboratory Medicine;Jul2009, Vol. 133 Issue 7, p1096 

    Context.-Nonneoplastic lung diseases include a wide range of pathologic disorders from asthma to interstitial lung disease to pulmonary hypertension. Recent advances in our understanding of the pathophysiology of many of these disorders may ultimately impact diagnosis, therapy, and prognosis. It...

  • Editorial. McCool, F. // Lung;Feb2012, Vol. 190 Issue 1, p1 

    The article discusses various issues published within the issue including the Third American Cough Conference held in New York City, pathophysiology of cough, and research studies related to lungs diseases.

  • PPARγ as a Potential Target to Treat Airway Mucus Hypersecretion in Chronic Airway Inflammatory Diseases. Yongchun Shen; Lei Chen; Tao Wang; Fuqiang Wen // PPAR Research;2012, Special section p1 

    Airway mucus hypersecretion (AMH) is a key pathophysiological feature of chronic airway inflammatory diseases such as bronchial asthma, cystic fibrosis, and chronic obstructive pulmonary disease. AMH contributes to the pathogenesis of chronic airway inflammatory diseases, and it is associated...

  • Экспериментальные модели эндометриоза: разные подходы для разных задач ПЕТРОСЯН, М. А. // Problemy Reproduktsii;2016, Vol. 22 Issue 5, p29 

    This review discusses the experimental models of endometriosis. The general idea about available approaches to the modeling of this disease in different animal species, namely primates, rodents, transgenic animals, as well as on the chorioallantoic membrane of the chicken embryo is presented....

  • Guidelines. Saudi Guidelines on the Diagnosis and Treatment of Pulmonary Hypertension: Pulmonary hypertension due to lung diseases and/or hypoxia. Sakkijha, Husam; Idrees, Majdy M. // Annals of Thoracic Medicine;Jul-Sep2014 Supplement 1, Vol. 9 Issue S1, p56 

    Chronic lung diseases are common causes of pulmonary hypertension. It ranks second after the left heart disease. Both obstructive and restrictive lung diseases are know to cause pulmonary hypertension. The pathophysiology of the disease is complex, and includes factors affecting the blood...

  • Potential benefits of ibuprofen in the treatment of viral respiratory infections. Winther, Birgit; Mygind, Neils // Inflammopharmacology;2003, Vol. 11 Issue 4-6, p445 

    Focuses on the pathophysiology of viral infection and diseases of the upper airways in relation to treatment with non-steroidal anti-inflammatory medication. Discussion on the generation of cold symptoms; Importance of rhinovirus as a pathogen in acute otitis media, acute sinusitis,...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sign out of this library

Other Topics